Proton Pump Inhibitor Kidney Disease
More than 15 million Americans who suffer from heartburn and acid reflux rely on a class of prescription drugs called proton pump inhibitors (PPIs), which work by reducing the amount of acid produced by the stomach. But researchers now believe patients who take PPIs may face an increased risk of developing severe health problems, including chronic kidney disease.
Our drug injury attorneys are here to help if you or a loved one developed chronic kidney disease or experienced kidney failure after taking a PPI drug, including:
At Ferrer, Poirot & Wansbrough, we’ve been helping drug injury victims for more than 30 years, and we have the legal knowledge and resources to help you get the best possible results for your case. Call (800) 210-8503 or complete a free initial consultation form to get help now. We’ll review your case for free, and you won’t owe us anything unless we win money for you.
PPI Heartburn Drugs Linked to Chronic Kidney Disease
In a study published in JAMA Internal Medicine, researchers analyzed data from more than 10,000 patients taking part in a national study and nearly 250,000 outpatients treated with PPIs. Findings showed patients who took PPIs once per day faced a 15 percent increased risk of chronic kidney disease compared to patients who didn’t take PPIs. Twice-daily users were 46 percent more likely to develop chronic kidney disease.
Researchers also found that patients who took PPIs faced a 39 percent higher risk of chronic kidney disease over patients of similar health treated with H2 blockers, another type of drug used to treat heartburn and acid reflux.
Proton Pump Inhibitor Kidney Disease Lawsuits
If you or someone you care about developed chronic kidney disease or experienced kidney failure after taking Nexium, Prevacid, Prilosec, Losec, Protonix, or Zegerid, you may be entitled to compensation. Ferrer, Poirot, and Wansbrough wants to help. Our team of compassionate drug injury lawyers can help answer your questions and protect your rights. Call (800) 210-8503 or complete a free initial consultation form to get started now.
Prilosec®, Losec®, and Nexium® are registered trademarks of AstraZeneca plc. Prevacid® is a registered trademark of Takeda Pharmaceuticals U.S.A., Inc. Protonix® is a registered trademark of Pfizer, Inc. Zegerid® is a registered trademark of Santarus, Inc. All trademarks are used to identify the products in question.
This law firm is not associated with, sponsored by, or affiliated with the American Medical Association; AstraZeneca plc; JAMA Internal Medicine; Pfizer, Inc.; Santarus, Inc.; or Takeda Pharmaceuticals U.S.A., Inc.